January 2009
PhI(OAc)2-Al2O3 Mediated Synthesis of 1,8-Naphthyridinyl-1,3,4-oxadiazoles
Under Microwave Irradiation
129
Table 1
Physical and analytical data of [o-(1,8-naphthyridin-2-yl)phenoxy]acetic acid arylidenehydrazides 4 and
5-aryl-2-[o-(1,8-naphthyridin-2-yl)phenoxymethyl]-1,3,4-oxadiazoles 5.
Found % (Calcd)
Reaction period
(min)
Entry
Ar
M.p. (ꢀC)
Yield (%)
Mol. formula
C
H
N
4a
4b
4c
4d
4e
4f
4g
4h
5a
5b
5c
5d
5e
5f
C6H5
1.0
0.5
1.5
1.0
1.5
0.5
1.0
1.5
5.0
4.5
5.5
5.0
6.0
6.5
5.5
6.5
184
176
234
180
200
210
96
98
94
97
94
92
93
92
90
95
92
93
90
88
89
87
C23H18N4O2
C24H20N4O2
C24H20N4O3
72.43 (72.25)
72.91 (72.73)
69.72 (69.90)
66.45 (66.27)
59.71 (59.87)
64.80 (64.64)
61.38 (61.20)
61.36 (61.20)
72.76 (72.63)
73.27 (73.10)
70.42 (70.24)
66.75 (66.59)
60.30 (60.13)
64.78 (64.94)
61.63 (61.47)
61.62 (61.47)
4.76 (4.71)
4.08 (5.05)
4.49 (4.85)
4.02 (4.08)
3.74 (3.69)
3.94 (3.98)
3.40 (3.55)
3.41 (3.55)
4.26 (4.21)
4.61 (4.57)
4.43 (4.39)
3.66 (3.62)
3.32 (3.27)
3.58 (3.53)
3.16 (3.12)
3.17 (3.12)
14.74 (14.66)
14.21 (14.14)
13.66 (13.59)
13.49 (13.45)
12.22 (12.15)
16.46 (16.39)
12.47 (12.42)
12.49 (12.42)
14.80 (14.74)
14.29 (14.21)
13.72 (13.66)
13.58 (13.51)
12.29 (12.20)
16.41 (16.47)
12.55 (12.47)
12.56 (12.47)
p-CH3C6H4
p-CH3OC6H4
p-ClC6H4
C23H17ClN4O2
C23H17BrN4O2
C23H17N5O4
o-BrC6H4
m-NO2C6H4
2,4-Cl2C6H3
2,6-Cl2C6H3
C6H5
p-CH3C6H4
p-CH3OC6H4
p-ClC6H4
185
223
C23H16Cl2N4O2
C23H16Cl2N4O2
C23H16N4O2
C24H18N4O2
C24H18N4O3
C23H15ClN4O2
C23H15BrN4O2
C23H15N5O4
C23H14Cl2N4O2
C23H14Cl2N4O2
>300
>300
>300
>300
>300
>300
>300
>300
o-BrC6H4
m-NO2C6H4
2,4-Cl2C6H3
2,6-Cl2C6H3
5g
5h
product was collected by filtration, washed with water, and re-
crystallized from ethanol to afford 4.
exposed to MWs at 800 watts intermittently at 30 s intervals
for the specific time (Table 1). After complete conversion as
indicated by TLC, the reaction mixture was cooled and treated
with methanol (30 mL). The methanol solution was poured
into ice-cold water (50 mL), the precipitated solid was col-
lected by filtration and re-crystallized from ethanol to furnish
5 (Table 1).
4a. IR: 3432, 1690, 1615 cmꢁ1 1H NMR (CDCl3): d 4.90
;
(s, 2H, CH2), 8.18 (m, 3H, C3AH, C4AH, C5AH), 7.92 (m,
1H, C6AH), 9.10 (m, 1H, C7AH), 6.92–7.55 (m, 10H, N¼¼CH,
9ArAH), 12.53 (s, 1H, CONH).
4b. IR: 3440, 1685, 1612 cmꢁ1 1H NMR (CDCl3): d 2.22
;
1
(s, 3H, CH3), 4.92 (s, 2H, CH2), 8.27 (m, 3H, C3AH, C4AH,
C5AH), 7.94 (m, 1H, C6AH), 9.12 (m, 1H, C7AH), 6.90–7.58
(m, 9H, N¼¼CH, 8ArAH), 12.36 (s, 1H, CONH).
5a. IR: 1605 cmꢁ1; H NMR (CDCl3 þ DMSO-d6): d 5.46
(s, 2H, CH2), 8.20 (m, 3H, C3AH, C4AH, C5AH), 8.00 (m,
1H, C6AH), 9.15 (m, 1H, C7AH), 7.04–7.60 (m, 9H, ArAH).
4c. IR: 3448, 1696, 1604 cmꢁ1
;
1H NMR (CDCl3): d 3.82
5b. IR: 1602 cmꢁ1; H NMR (CDCl3 þ DMSO-d6): d 2.30
1
s, 3H, OCH3), 4.91 (s, 2H, CH2), 8.28 (m, 3H, C3AH, C4AH,
C5AH), 7.98 (m, 1H, C6AH), 9.13 (m, 1H, C7AH), 6.83–7.80
(m, 9H, N¼¼CH, 8ArAH), 12.42 (s, 1H, CONH).
(s, 3H, CH3), 5.42 (s, 2H, CH2), 8.18 (m, 3H, C3AH, C4AH,
C5AH), 7.98 (m, 1H, C6AH), 9.14 (m, 1H, C7AH), 7.00–7.56
(m, 8H, ArAH).
4d. IR: 3420, 1702, 1609 cmꢁ1
;
1H NMR (CDCl3): d 4.94
5c. IR: 1604 cmꢁ1; H NMR (CDCl3 þ DMSO-d6): d 3.87
1
(s, 2H, CH2), 8.25 (m, 3H, C3AH, C4AH, C5AH), 8.00 (m,
1H, C6AH), 9.13 (m, 1H, C7AH), 7.03–7.80 (m, 9H, N¼¼CH,
8ArAH), 12.89 (s, 1H, CONH).
(s, 3H, OCH3), 5.41 (s, 2H, CH2), 8.17 (m, 3H, C3AH, C4AH,
C5AH), 7.92 (m, 1H, C6AH), 9.12 (m, 1H, C7AH), 6.92–7.60
(m, 8H, ArAH).
4e. IR: 3450, 1705, 1604 cmꢁ1
;
1H NMR (CDCl3): d 4.92
5d. IR: 1605 cmꢁ1; H NMR (CDCl3 þ DMSO-d6): d 5.43
1
(s, 2H, CH2), 8.20 (m, 3H, C3AH, C4AH, C5AH), 7.93 (m,
1H, C6AH), 9.14 (m, 1H, C7AH), 7.00–7.73 (m, 9H, N¼¼CH,
8ArAH), 12.89 (s, 1H, CONH).
(s, 2H, CH2), 8.20 (m, 3H, C3AH, C4AH, C5AH), 7.81 (m,
1H, C6AH), 9.09 (m, 1H, C7AH), 7.10–7.32 (m, 8H, ArAH).
1
5e. IR: 1602 cmꢁ1; H NMR (CDCl3 þ DMSO-d6): d 5.46
4f. IR: 3435, 1697, 1604 cmꢁ1
;
1H NMR (CDCl3): d 4.95
(s, 2H, CH2), 8.23 (m, 3H, C3AH, C4AH, C5AH), 7.92 (m,
1H, C6AH), 9.03 (m, 1H, C7AH), 7.20–7.74 (m, 8H, ArAH).
(s, 2H, CH2), 8.17 (m, 3H, C3AH, C4AH, C5AH), 7.91 (m,
1H, C6AH), 9.08 (m, 1H, C7AH), 6.90–7.49 (m, 9H, N¼¼CH,
8ArAH), 12.42 (s, 1H, CONH).
1
5f. IR: 1603 cmꢁ1; H NMR (CDCl3 þ DMSO-d6): d 5.42
(s, 2H, CH2), 8.21 (m, 3H, C3AH, C4AH, C5AH), 7.97 (m,
1H, C6AH), 9.11 (m, 1H, C7AH), 7.05–7.52 (m, 8H, ArAH).
4g. IR: 3425, 1702, 1607 cmꢁ1 1H NMR (CDCl3): d 4.92
;
1
(s, 2H, CH2), 8.24 (m, 3H, C3AH, C4AH, C5AH), 7.95 (m,
1H, C6AH), 9.10 (m, 1H, C7AH), 6.98–7.62 (m, 8H, N¼¼CH,
7ArAH), 12.52 (s, 1H, CONH).
5g. IR: 1600 cmꢁ1; H NMR (CDCl3 þ DMSO-d6): d 5.45
(s, 2H, CH2), 8.19 (m, 3H, C3AH, C4AH, C5AH), 7.92 (m,
1H, C6AH), 9.13 (m, 1H, C7AH), 6.94–7.56 (m, 7H, ArAH).
4h. IR: 3422, 1707, 1604 cmꢁ1
;
1H NMR (CDCl3): d 4.90
5h. IR: 1601 cmꢁ1
5.43 (s, 2H, CH2), 8.21 (m, 3H, C3AH, C4AH, C5AH),
7.98 (m, 1H, C6AH), 9.10 (m, 1H, C7AH), 7.01–7.52 (m,
7H, ArAH).
;
1H NMR (CDCl3 þ DMSO-d6): d
(s, 2H, CH2), 8.19 (m, 3H, C3AH, C4AH, C5AH), 7.90 (m,
1H, C6AH), 9.12 (m, 1H, C7AH), 6.96–7.58 (m, 8H, N¼¼CH,
7ArAH), 12.73 (s, 1H, CONH).
General procedure for the synthesis of 5-aryl-2-
[o-(1,8-naphthyridin-2-yl)-phenoxymethyl]-1,3,4-oxadiazoles
5. Compound 4 (0.01 mol) and PhI(OAc)2 (0.01 mol)
doped on neutral alumina (1 g) are mixed thoroughly and
Acknowledgment. The authors thank the Directors, IICT,
Hyderabad and IITM, Chennai for providing spectroscopic and
analytical data.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet